Wall Street Zen upgrades Ambev stock to Buy

Published on 10/28/2026 at 06:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q2 normalized EBITDA rose 8.9 percent to BRL 6.4 billion. Ambev stock heads into October 29 results after margin reached 31.6 percent.

Analyst signals and operating figures

Wall Street Zen upgraded Ambev from Hold to Buy on October 10, 2026.
Normalized EBITDA rose 8.9 percent in the second quarter of 2026.
Ambev's market capitalization was USD 44.2 billion as of October 27, 2026.
Ambev stock was last at USD 2.87 on the NYSE on October 27, 2026.

ABEV, US02319V1035, Illustration mit AI erstellt.

Ambev (ISIN US02319V1035) was upgraded from Hold to Buy by Wall Street Zen on October 10, 2026, according to MarketBeat. The change leaves Ambev with a mixed analyst picture ahead of its next quarterly report.

Three analyst signals since October

On October 7, 2026, B of A Securities downgraded Ambev to Underperform while maintaining a USD 3.30 price target, according to Benzinga. On October 8, 2026, Weiss Ratings raised its view from Hold to Buy. On October 10, 2026, Wall Street Zen also raised Ambev from Hold to Buy, according to MarketBeat.

What does the quarter show?

Ambev's second-quarter 2026 net revenue reached BRL 20.15 billion, up 6.1 percent organically from the second quarter of 2025. Normalized EBITDA rose 8.9 percent to BRL 6.38 billion, while the normalized EBITDA margin expanded to 31.6 percent from 30.6 percent, according to the company's filing with the SEC. Operating cash flow increased 54.5 percent to BRL 4.71 billion in the same period.

What comes next for Ambev?

Ambev's investor-relations calendar schedules third-quarter 2026 results for October 29, 2026, before the opening of the B3 and NYSE, according to Ambev. A separate market schedule lists full-year 2026 results for March 4, 2027, according to Barron's.

How does valuation frame the move?

Ambev's market capitalization was USD 44.2 billion as of October 27, 2026. The same dated market picture placed the 52-week range at USD 2.18 to USD 3.45, giving the upcoming report a clear valuation backdrop without resolving the split between cautious and positive analyst views.

NYSE quote and reporting date

Ambev ADR was last at USD 2.87 on the NYSE on October 27, 2026 at 4:00 p.m. ET. The October 29 reporting date is the next concrete test for the operating gains reported in the second quarter. The further course of trading is shown by the continuously updated real-time quote of Ambev stock.